跳至主要内容
临床试验/DRKS00020388
DRKS00020388已完成未知

Postmarket Study of outcomes from WaveLight® EX500 InnovEyes™ treatment in conjunction with the InnovEyes™ Sightmap - RFP911-P001

Alcon Research, LLC0 个研究点目标入组 136 人开始时间: 2020年3月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
136

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
21 Years 至 one(—)
性别
All

入选标准

  • •Minimum of 21 years of age
  • •- Myopia up to and including -11.00 D with or without astigmatism up to -4.50 D
  • •- BCDVA of 20/20 or better
  • •Other protocol-defined inclusion criteria may apply

排除标准

  • •- Acute or chronic disease or illness that would increase the operative risk or confound the outcomes of the study.
  • •- Previous intraocular or corneal surgery
  • •- Participation in other clinical trials during the course of the study that may
  • •confound study results
  • •Other protocol-defined exclusion criteria may apply.

研究者

相似试验

Postmarket Study of outcomes from WaveLight® EX500... | 临床试验